Human Apelin (APLN) activation kit by CRISPRa

CAT#: GA105899

APLN CRISPRa kit - CRISPR gene activation of human apelin



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
APLN rabbit polyclonal antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00


APLN (Myc-DDK-tagged)-Human apelin (APLN)
    • 10 ug

CNY 1,800.00
CNY 3,705.00


APLN rabbit polyclonal antibody
    • 25 ul

CNY 800.00
CNY 1,280.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol APLN
Locus ID 8862
Kit Components

GA105899G1, Apelin gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA105899G2, Apelin gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA105899G3, Apelin gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_017413
Synonyms APEL; XNPEP2
Summary This gene encodes a peptide that functions as an endogenous ligand for the G-protein coupled apelin receptor. The encoded preproprotein is proteolytically processed into biologically active C-terminal peptide fragments. These peptide fragments activate different tissue specific signaling pathways that regulate diverse biological functions including fluid homeostasis, cardiovascular function and insulin secretion. This protein also functions as a coreceptor for the human immunodeficiency virus 1. [provided by RefSeq, Feb 2016]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...